RSS

drug resistant infections

The Access to Medicine Foundation has published an independent analysis of the efforts made by pharma companies to address the issue of drug resistant infections. more

Analysis

A specialist in therapeutic approaches to treat resistant bacterial infections, Mutabilis has been selected to join the European consortium ENABLE — aimed at developing antibiotics to tackle infections caused by multi-resistant gram-negative bacteria more

News

Biopharmaceutical company, Antabio, has completed a €7.3 million series A financing round for the development of novel therapies to treat drug-resistant gram-negative infections. more

News

A research team from the Netherlands Cancer Institute has discovered the underlying mechanism to why cancer cells become addicted to the drugs that are administered to kill them, which may lead to more rational alternating therapies. more

News

World health experts gathered at the University of Edinburgh yesterday to find new ways of fighting antibiotic resistant infections more

News

BioInfect will take place on 10 November 2015 at Alderley Park, Cheshire more

News